Oral Testosterone Administration Detected by Testosterone Glucuronidation Measured in Blood Spots Dried on Filter Paper
|
|
- Daisy Higgins
- 6 years ago
- Views:
Transcription
1 Clinical Chemistry 46: (2000) Drug Monitoring and Toxicology Oral Testosterone Administration Detected by Testosterone Glucuronidation Measured in Blood Spots Dried on Filter Paper Shi-Hua Peng, 1 Jordi Segura, 1,2* Magí Farré, 1,3 and Xavier de la Torre 1,3 Background: Blood sampling is not a common practice for sports drug testing. Our aim was to investigate whether dried blood spots on filter paper could be an alternative to plasma samples for monitoring steroid profiles in dope testing. Methods: We collected dried blood spots and plasma from six healthy Caucasian subjects after an oral 120-mg dose of testosterone undecanoate (TU). Nonconjugated testosterone, testosterone glucuronide (TG), androsterone glucuronide (AG), and etiocholanolone glucuronide (EtG) were measured by gas chromatography mass spectrometry in both matrices. 17 -Hydroxyprogesterone (17 OHP) and luteinizing hormone (LH) also were measured in the plasma samples. For comparison, similar measurements were done on samples obtained from the same subjects given 25 mg of testosterone propionate (TP) plus 110 mg of testosterone enanthate (TE) intramuscularly after a wash-out period. Results: After oral TU intake, TG, AG, and EtG increased sharply, whereas nonconjugated testosterone did not change significantly. Results on dried blood spots correlated well with those on plasma. The TG/ testosterone ratio in blood or plasma was verified to be a sensitive and specific marker (significantly increased for up to 8 h after intake; P <0.05) for oral TU intake but not for intramuscular administration of TP plus TE. Little suppression of plasma LH and 17 OHP was observed after a single oral dose of TU. One subject did not show a significant increase of blood TG after oral TU intake. Conclusions: The measurement of glucuronide conjugates in blood and plasma samples is relevant for sports drug testing when analyzing the steroid profile. Dried blood spots collected on filter paper are a suitable alternative to plasma for detecting testosterone abuse American Association for Clinical Chemistry In recent years, there has been an increase of doping with endogenous-like substances, such as testosterone and some of its metabolic precursors. Discriminating the exogenous intake of these substances from their endogenous origin constitutes a challenge in today s sports drug testing. Pharmaceutical testosterone preparations are commercially available for oral, percutaneous, and intramuscular administration. The International Olympic Committee criterion for suspecting exogenous testosterone intake, a urinary concentration ratio of testosterone glucuronide to epitestosterone glucuronide (TG/EG) 4 6 (1), needs elaborate follow-up for definitive decisions. There are a few subjects who have physiologically increased urinary TG/EG ratios, whereas other individuals do not show a TG/EG ratio 6 even after exogenous intake of testosterone (2, 3). In addition, oral administration of testosterone produces a high but brief increase in the urinary TG/EG ratio (4), which probably would be difficult to detect (as judged by the criterion TG/EG 6) as an indication of exogenous testosterone intake when urine is collected after a sporting event (which usually includes a 1-h delay plus an additional waiting period for the final collection of urine). Apart from measurement of the 13 C content of urinary testosterone metabolites by isotope-ratio mass spectrometry (5), a theoretically better approach might be to analyze one drop of blood collected immediately after the sporting event. The sample may be 1 Institut Municipal d Investigació Mèdica, E Barcelona, Spain. 2 Universitat Pompeu Fabra, Barcelona, Spain. 3 Universitat Autónoma de Barcelona, Barcelona, Spain. *Address correspondence to this author at: Drug Research Unit, Institut Municipal d Investigació Mèdica (IMIM), Doctor Aiguader 80, E Barcelona, Spain. Fax ; jsegura@imim.es. Received October 22, 1999; accepted January 18, Nonstandard abbreviations: TG, testosterone glucuronide; EG, epitestosterone glucuronide; TU, testosterone undecanoate; AG, androsterone glucuronide; EtG, etiocholanolone glucuronide; 17 OHP, 17 -hydroxyprogesterone; T-D 3, testosterone-[16,16,17]-d 3 ; Et-D 4, etiocholanolone-[2,2,4,4]-d 4 ; TP, testosterone propionate; TE, testosterone enanthate; GC, gas chromatography; MS, mass spectrometry; TMS, trimethylsilyl; LH, luteinizing hormone; and TG/T, testosterone glucuronide/testosterone. 515
2 516 Peng et al.: Dried Blood Spots and Testosterone Abuse obtained by fingerprick or earprick, which currently are used for lactic acid and other measurements. The relevant question is whether suitable information from adequate markers can be obtained from such a small amount of sample. In the present study, one 120-mg dose of testosterone undecanoate (TU) was administrated orally to six healthy Caucasian volunteers. Dried blood spots and plasma samples were collected and studied for biological indicators of exogenous testosterone intake. Materials and Methods references, steroids, and chemicals Testosterone, testosterone glucuronide (TG), androsterone, androsterone glucuronide (AG), etiocholanolone, etiocholanolone glucuronide (EtG), 17 -hydroxyprogesterone (17 OHP), and Escherichia coli -glucuronidase were purchased from Sigma. Testosterone-[16,16,17]-d 3 (T-D 3 ) and etiocholanolone-[2,2,4,4]-d 4 (Et-D 4 ) were kindly provided by the late Prof. M. Donike (Deutsche Sporthochschule, Cologne, Germany). N-Methyl-N-trimethylsilyl-trifluoroacetamide was provided by Macherey-Nagel (Düren, Germany). Ammonium iodide and 2-mercaptoethanol were obtained from Merck. All other reagents were of analytical grade. sample collection Six healthy male Spanish volunteers (subjects 1 6; age, years; weight, kg; height, m, mean SD) received a single oral 120-mg dose of TU (Androxon, three 40-mg capsules; Organon). Venous blood (10 ml) was collected from the antecubital vein before and after administration. Sampling times were 0.5h( 0.5 h) before administration, at administration (0 h; 0900 in the morning), and 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, and 12 h after administration. Aliquots of 20 L of fresh blood were spotted onto filter paper (Whatman 41), and then air dried, sealed in plastic bags, and stored at 20 C until analysis. The remaining heparinized whole blood was centrifuged for preparing plasma samples. To check the stability of steroids in blood spots dried on filter paper, aliquots of blood spot samples (stored at 20 C) from each of the six volunteers obtained 1 h after the oral TU administration were removed from the freezer and kept at room temperature for 1 week. These aliquots were analyzed for steroid profiles simultaneously with the corresponding aliquots stored at 20 C from the time of collection. After a wash-out period of 3 months, the same six subjects received a single intramuscular dose of Testoviron Depot 100 [25 mg of testosterone propionate (TP) plus 110 mg of testosterone enanthate (TE); Schering AB]. Blood spots and plasma samples were collected and stored as described above. The sampling times were on days 3 (0900), 2 (0900), 1 (0900) before administration; at 0 h (0900), 6 h (1500), and 12 h (2100) after administration (on day 0), on days 1 and 2 at 0 h (0900) and 8 h (1700) on days 3 and 4; and at 0 h (0900) on days 5, 6, 7, 8, 9, 11, 13, 15, 17, and 19 after administration. Approval for the above-described clinical trials was granted by the local ethics committee (CEIC no. 94/467) and by the Spanish Health Ministry (DGFPS no. 95/75). sample preparation Dried blood spots. For the extraction of nonconjugated steroids from blood spots on filter paper, two dried blood spots were cut with scissors in small pieces into a tube, and 2.5 ml of sodium phosphate buffer (0.2 mol/l, ph 7) was added. T-D 3 and Et-D 4 were used as internal standards at final concentrations of 0.9 and 5 g/l, respectively, in buffer. Immediately after the subsequent addition of 100 L of 3 mol/l potassium hydroxide, the samples were extracted twice with 5 ml of n-hexane:ethyl acetate (7:3, by volume), using a rocking mixer for 20 min to extract nonconjugated steroids. It has been verified that under these conditions there is no hydrolysis of testosterone esters, which could increase the actual amount of testosterone initially present in the sample. The organic phases were pipetted out into a tube, mixed, and washed with 1 ml of 50 ml/l acetic acid and then with 1 ml of distilled water. After the solvent was evaporated, the residue was kept in a desiccator maintained at 60 C and 60 kpa (phosphorous pentoxide was used as desiccant, which was changed when formation of phosphoric acid was quite notable) at least 30 min before derivatization (see below). For the extraction of glucuronide-conjugated steroids, the extracted potassium hydroxide-water phase indicated above was neutralized with 1 mol/l hydrochloric acid, incubated with 6Uof -glucuronidase at 37 C overnight after a second addition of the same amounts of the same (T-D 3 and Et-D 4 ) internal standards, and then extracted with t-butyl methyl ether after the aqueous solution was adjusted to approximately ph 10 with 50 g/l potassium carbonate. After the solvent was evaporated, the residue was kept in a desiccator at least 30 min before derivatization. The dried extracts were derivatized for gas chromatography mass spectrometry (GC-MS) analysis. Trimethylsilyl (TMS) derivatives of steroids in both extracts were prepared by dissolving the dried residues in 50 L of a mixture containing1lofn-methyl- N-trimethylsilyl-trifluoroacetamide, 2 g of ammonium iodide, and 6 ml of 2-mercaptoethanol and heating at 60 C for 30 min. Each solution (1 2 L) was directly analyzed by GC-MS. Endogenous steroids (testosterone, androsterone, and etiocholanolone) were quantified using the responses of the target compounds relative to the internal standards, calculated from an extracted sample of distilled water containing 1.2 g/l testosterone, 20 g/l androsterone, and 20 g/l etiocholanolone [extracted with hexane-ethyl acetate (7:3, by volume)]. Plasma. A 1-mL plasma sample was diluted with 1.5 ml of sodium phosphate buffer (0.2 mol/l, ph 7) and subjected to a procedure similar to that for the analysis for urine in
3 Clinical Chemistry 46, No. 4, sports drug testing (6), with modifications. Briefly, the diluted plasma sample was loaded on a Detectabuse TM column pretreated with methanol and water. The column was washed with water, and the steroids were eluted with methanol. The solvent was evaporated, and the residue was reconstituted in 1 ml of sodium phosphate buffer (0.2 mol/l, ph 7). Nonconjugated steroids (containing testosterone and 17 OHP) were extracted with 5 ml of t-butyl methyl ether, evaporated with nitrogen, and kept in a desiccator until derivatization. The remaining aqueous phase (containing TG, AG, and EtG) was then hydrolyzed with6uof -glucuronidase and extracted using the same procedure that was used for the blood-spot samples. Quantification of steroids (including 17 OHP) in both fractions of plasma was performed as for the blood spots samples, with modifications that included a water calibration mixture containing 5 g/l 17 OHP, 12 g/l testosterone, 200 g/l androsterone and 200 g/l etiocholanolone, and monitoring the tris-tms derivative of 17 OHP in the nonconjugated fraction extracted from plasma. Pooled plasma samples and pooled plasma samples supplemented with testosterone, TG, AG, and 17 OHP were run in each analytical batch as qualitycontrol samples. The intra- and interassay variabilities (CVs) were from 2.7% (for 12.7 nmol/l testosterone) to 15% (for 0.82 nmol/l TG). Accuracy (relative error) was from 0.8% (for 29.6 nmol/l EtG) to 15.1% (for 135 nmol/l AG). Luteinizing hormone (LH) was analyzed by microparticle enzyme immunoassay (Abbott) directly in plasma according to the manufacturer s instructions. gc-ms analysis A Hewlett-Packard 5890 II GC model fitted with a HP 7673A autosampler was connected to a HP 5970 massselective detector. The separation was carried out using a methyl silicone fused-silica capillary column [HP Ultra-1; 17 m 0.2 mm (i.d.); film thickness, 0.11 m] with the following oven temperature program: initial temperature of 180 C, ramped to 230 C at a rate of 3.0 C/min, then to 310 C at a rate of 40 C/min, and held for 3 min. Helium was used as carrier gas with a flow rate of 0.8 ml/min (measured at 180 C). The injector (operated in 10:1 split mode) and the interface were maintained at 280 C. The mass spectrometer was operated in selectedion monitoring acquisition mode with one or more ions selected for each substance (m/z 432, 434, and 434 for bis-tms derivatives of testosterone, androsterone and etiocholanolone, respectively; m/z 435 and 438 for bis-tms derivatives of T-D 3 and Et-D 4, respectively; m/z 546 for tris-tms derivative of 17 OHP). statistical analysis The concentrations in blood collected on filter paper and in plasma, and their ratios (log-transformed) after administration of TU were compared to their basal values by ANOVA for testing of significant differences. Results blood steroid profile analyzed in dried blood spots The nonconjugated testosterone measured in dried blood spots after oral administration of TU did not change significantly. Instead TG, which had an extremely low basal concentration in dried blood spots (much lower than nonconjugated testosterone), increased substantially after oral administration of TU in all of the subjects (Table 1) except one (subject 3). Results for the abnormal subject are discussed separately. Other main metabolites of testosterone, such as AG and EtG, were also significantly increased in these five subjects. Thus, hydrolysis of the dried blood sample plays an important role in the interpretation of results. TG, AG, and EtG increased significantly (compared with their basal concentrations) up to 8, 8, and 12 h, respectively (Fig. 1). Because of its extremely low basal concentration, TG showed the highest relative increase. Accordingly, for this report, the concept of steroid profile will refer specifically to those concentrations of testosterone, TG, AG, and EtG. Table 1. Time course of blood steroid concentrations (mean SE; n 5) and TG/T ratio after a single oral 120-mg dose of TU. Time, h Testosterone, nmol/l TG, nmol/l AG, nmol/l EtG, nmol/l TG/T a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a P 0.05 compared with basal values.
4 518 Peng et al.: Dried Blood Spots and Testosterone Abuse at room temperature were 5.9%, 2.8%, 6.9%, and 4.8%, respectively. Fig. 1. Mean relative increases ([increase/basal concentration] 100; n 5) of TG, AG, and EtG obtained from blood spots dried on filter paper after oral administration of 120 mg of TU. y axis is in logarithmic scale. correlation with plasma steroid profile The above-mentioned steroids and their glucuronides were analyzed in plasma samples obtained at the same time. Similar patterns between blood collected on filter paper and plasma were observed, with slightly higher values obtained in blood (Fig. 2). stability of steroid glucuronides in dried blood spots It is known that androgenic anabolic steroids, such as testosterone and 17 OHP, are stable in dried blood spots (7, 8). The stability of the glucuronides of some steroids in dried blood spots stored for 1 week at room temperature, compared with aliquots maintained in a freezer ( 20 C), was verified (Fig. 3). All four steroids measured (TG, testosterone, AG, and EtG) were sufficiently stable during the study period. The mean relative changes in TG, testosterone, AG, and EtG for the six subjects after 1 week specificity of tg/testosterone as a marker of oral administration To check whether the ratio of TG to testosterone (TG/T) in dried blood spots could be a specific marker for oral vs intramuscular administration of testosterone, dried blood-spot samples from the same six subjects, who received intramuscular injections with a single combined dose of 25 mg of TP plus 110 mg of TE were partially analyzed for steroid profiles. In the first step, all of the dried blood spots from one subject (subject 2) after intramuscular administration were studied. Testosterone, AG, and EtG, but not TG, were clearly increased after intramuscular administration. The highest increase of nonconjugated testosterone was found in those blood spots on filter paper collected between 1.25 and 2.25 days after intramuscular administration of TP plus TE, which is in good agreement with the pharmacokinetic profile known for the same type of preparation and obtained by either RIA (9) or GC-MS (10). In the next step, samples obtained 1 day before ( 1 day), and 2.25 and 19 days after ( 2.25 and 19 days) intramuscular administration from each subject were selected for a more comprehensive analysis. For all the six subjects, nonconjugated testosterone at 2.25 days was increased (relative increases, %) compared with its basal concentration, whereas no meaningful changes of TG were observed. However, clear increases of AG and EtG were also observed in the blood collected 2.25 days after intramuscular dosing of testosterone esters. The results are shown in Fig. 4. The results obtained from corresponding plasma samples are also presented. When comparing these results with the changes in steroid profiles observed in blood after oral intake of testosterone, testosterone glucuronida- Fig. 2. Mean concentrations (n 5) of testosterone, TG, AG, and EtG in blood spots and plasma after oral administration of 120 mg of TU. y axis is in logarithmic scale. f, testosterone in dried blood spots;, testosterone in plasma samples; Œ, TG in dried blood spots;, TGin plasma samples;, AG in dried blood spots;, AG in plasma samples; F, EtG in dried blood spots; E, EtG in plasma samples. Conc., concentration.
5 Clinical Chemistry 46, No. 4, Fig. 3. Stability of TG, nonconjugated testosterone, AG, and EtG in blood spots dried on filter paper after oral administration of 120 mg of TU. One aliquot was kept at 20 C in freezer ( ); another aliquot was kept at room temperature for 1 week (f). T, nonconjugated testosterone; sub, subject; Conc., concentration. tion in human blood appears to be a specific marker for oral testosterone intake. other markers (tg/lh, tg/17 ohp, and tg/eg) Recently, plasma T/LH and T/17 OHP have been suggested as sensitive markers of testosterone administration, based on the observation that lower concentrations of plasma LH and 17 OHP could be induced by intramuscular administration of exogenous testosterone (11 13). However, a single oral administration of TU seems unlikely to cause significant suppression of LH secretion and steroidogenesis. LH concentrations showed no meaningful changes during 0 24 h post administration, whereas 17 OHP showed only a small reduction. As shown in Table 2, plasma TG/17 OHP was affected, but mainly because of an increase in TG rather than a decrease in 17 OHP. In addition, plasma TG/17 OHP and TG/LH were significantly increased above their basal concentrations until 10 and 6 h, respectively, post administration. TG/EG in urine was 6 in all subjects but subject 3 in the period 0 4 h, and in three subjects in the period 4 8 h post administration (14). outlier subject One subject (subject 3; Table 3) did not show significant changes of TG in plasma but did show a transient (1 2 h) increase in nonconjugated testosterone after TU administration. The AG and EtG concentrations in his dried blood spots on filter paper did present remarkable increases. It has been verified that his urinary TG/EG ratio remained 2 during the whole controlled study (14). Discussion The clear increase of TG measured in dried blood spots of five of six subjects after oral administration of TU appears to be an efficient marker for exogenous intake of testosterone. Regarding the extremely low basal concentration of TG and relative higher basal concentration of testosterone, the TG/T ratio is a sensitive marker for oral TU administration. In the late 1970s, when oral TU preparations were studied as potential new supplements for hypogonadal deficiency or fertility control, clinical endocrinologists monitored extensively the effect of oral TU on the plasma concentration of nonconjugated testosterone after oral TU administration (15 17). It was reported that after a single oral dose of TU, there were significant increases of nonconjugated testosterone in both saliva and serum, as detected by RIA (18, 19), which seems in apparent disagreement with the absence of significant changes of nonconjugated testosterone in plasma and dried blood spots observed in the present study by GC-MS. It is
6 520 Peng et al.: Dried Blood Spots and Testosterone Abuse Table 2. Time course of some plasma markers (mean SE; n 5) after a single oral 120-mg dose of TU. Time, h TG/T TG/17 OHP TG/LH a a a a a a a a a a a a a a a a a a a a a a a a a a P 0.05 compared with basal values. Fig. 4. Mean dried blood-spot (A) and plasma (B) steroid profile [testosterone, TG, AG, and EtG; n 6] after administration of one intramuscular combined dose of 25 mg of TP plus 110 mg of TE. u, 1 day before administration ( 1 day); f, 2.25 days after administration ( 2.25 days);, 19 days after administration ( 19 days). T, testosterone; Conc., concentration. feasible that some cross-reactivity ( 0.2%) (18) of the RIA antiserum used in those previous studies for TU could produce an apparent increase of nonconjugated testosterone, because the unchanged TU is also extracted by the solvent extraction method used in those studies. In fact, the existence of substantial amounts of TU in plasma after oral TU administration is known (20) and was confirmed in those subjects (14). The additional thin-layer chromatographic clean-up of nonconjugated testosterone preceding the RIA assay in some of these previous studies (18), however, seems to preclude such an easy explanation. Differences in the health status of the subjects in the present study (healthy) and the previous study (patients) might be relevant to the differences between the results, perhaps because the differences in health status affected the preferential absorption route of TU (see below). Although no definitive explanation could be given for the above-mentioned apparently conflicting results obtained by RIA and GC-MS techniques, the changes in nonconjugated testosterone and TG in plasma in the present study do agree with the results obtained in a controlled study by Dehennin and Pérès (21), who used a GC-MS analytical technique to monitor seven healthy subjects who received a single oral combined dose of 40 mg of TU plus 1.5 mg of epitestosterone undecanoate. Moreover, a sharp increase of TG compared with nonconjugated testosterone in the plasma of one healthy subject after a single oral dose of 80 mg of TU was observed by Giagulli et al. (22), using RIA assay after paper chromatographic purification. It is generally considered that esterification of testosterone with undecanoic acid shifts the route of absorption from the portal vein to the lymph system (23) and that TU enters the blood via the thoracic duct. However, the remarkable increase of TG in plasma after oral TU administration observed here suggests that a substantial percentage of TU may be absorbed via the portal vein, probably losing the undecanoate group in the intestine, whereas the remaining nonmetabolized TU could be absorbed via the lymphatic system, as suggested by Coert et al. (24) in a controlled study of rats after oral TU administration. This hypothesis is supported by the observation that plasma TG was sharply increased post Table 3. Time course of blood steroid concentrations from subject 3 after a single oral 120-mg dose of TU. Time, h Testosterone, nmol/l TG, nmol/l AG, nmol/l EtG, nmol/l TG/T
7 Clinical Chemistry 46, No. 4, administration, with the mean peak concentration being reached at 1 h after the dosing, whereas unchanged TU was found in plasma of all the six subjects receiving oral TU, with the mean peak concentration appearing at 3 h after the dosing (14). AG and EtG were increased in blood of all six subjects studied either after oral administration of TU or after intramuscular administration of combined TP plus TE. Thus, increases of AG and EtG in blood, compared with their basal concentrations, seem to be indicative of exogenous testosterone intake, regardless of the administration route. Given the relevance of glucuronidation of testosterone, androsterone, and etiocholanolone, analysis with and without hydrolysis of blood and plasma samples appears necessary for obtaining the proper steroid profile after exogenous testosterone intake, especially after oral administration. However, one subject showed no increase in TG but a very short increase in nonconjugated testosterone, and longer-lasting clear increases of AG and EtG after oral intake of TU. This subject did show a similar total recovery of testosterone excreted in urine after TU administration compared with the other five subjects (data not shown), as calculated by the addition of its main urinary metabolites, thus ruling out the possibility of poor gastrointestinal absorption of TU. Some other possibilities for his abnormal kinetic results could be a faster metabolism of testosterone to androsterone and etiocholanolone, a specific enzyme deficiency for testosterone glucuronidation in splanchnic organs, or again, a different balance between the portal vein vs lymphatic absorption, as mentioned above. At present, blood sampling is not a common practice in sports drug testing, although expectations for its future use are strong, especially for detecting the administration of peptide hormones (25). In the present study, the steroid profile (testosterone, TG, AG, and EtG) measured in blood spots dried on filter paper correlated well with that obtained from plasma, with the advantages of slightly higher concentrations being found in dried whole blood, which suggest that blood cells may retain small portions of testosterone and its glucuronide-conjugated metabolites. Thus, dried blood spots on filter paper could be an optimal alternative to plasma for assessing individual steroid profiles, with the advantages of the small volume of blood needed, easy collection by fingerprick or earprick, and less invasiveness. Blood TG/T obtained from dried blood spots was increased until 8 h after administration, whereas other plasma markers, TG/ 17 OHP and TG/LH, were significantly increased until 10 and 6 h, respectively, all confirming the signs of administration of testosterone. It has also been verified in the present study that steroids in dried blood spots are quite stable and that the samples can be stored easily and transported from the field to laboratories. Additionally, blood spots may be subjected to individual DNA fingerprinting, which may offer definitive proof of the authenticity of the sample. Taking into account the abovementioned merits of blood spots dried on filter paper as a sampling technique, it could be feasible that a database of basal blood steroid concentrations for each athlete be established and filed as historical fingerprints for doping control. Thus, changes in blood concentrations of TG, AG, and EtG, compared with historical basal concentrations for each particular athlete, would be easily detectable in dried blood spots. The existence of intact testosterone esters, which also can be detected in blood spots dried on filter paper, may offer additional unequivocal confirmation of testosterone intake. In fact, traces of the unchanged testosterone ester of orally administrated TU have been detected in some of these dried blood-spot samples, as reported previously (14). In conclusion, the ability of dried blood spots to provide reliable information on the glucuronidation of testosterone and its main metabolites (androsterone and etiocholanolone), which can be obtained by analyzing only one or two dried blood spots on filter paper, make this sample material a good alternative to plasma as a complement to urinalysis for detecting testosterone abuse. However, it should be kept in mind that the present proposed markers are derived from a small group of subjects. For the wide application of blood TG/T, AG, and EtG to detect testosterone abuse in doping tests, relevant population reference values and intraindividual variations should be taken into consideration and be studied carefully. The usefulness of easily obtained capillary blood (from a fingerprick or earprick), compared with drops of venous blood (studied in the present work), should also be verified for widespread applicability of the proposed approach. We thank the Spanish and Catalonian research administrations (projects FIS 96/1050, CICYT SAF , and CIRIT DOGC 2320) for financial support. S-H. Peng also thanks the Spanish Ministry of Science and Education for a postdoctoral fellowship. We thank Pere Roset, Marta Mas, and Esther Menoyo for their work in the clinical trials and some assistance in statistical analysis. References 1. Donike M, Barwald KR, Klostermann K, Schänzer W, Zimmermann J. Nachweis von exogenen Testosteron. In: Heck H, Hollmann W, Liesen H, Rost R, eds. Sport: Leistung und Gesundheit. Köln: Deutscher Arzte Verlag, 1983: Geyer H, Schänzer W, Mareck-Engelke U, Donike M. Factors influencing steroid profile. In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (3): proceedings of the Manfred Donike Workshop on Dope Analysis. Köln: Sport und Buch Strauss, 1996: de la Torre X, Segura J, Yang ZY, Ye L, Wu M. Testosterone detection in different ethnic group. In: Schänzer W, Geyer H, Gotzman A, Mareck-Engelke U, eds. Recent advances in doping
8 522 Peng et al.: Dried Blood Spots and Testosterone Abuse analysis (4): proceedings of the Manfred Donike Workshop on Dope Analysis. Köln: Sport und Buch Strauss, 1997: Wright F, Lafarge JP, Antréassian J, Lagoguey M, Péres G. Long term study of steroid and peptidic hormones in the plasma of healthy young men under controlled testosterone undecanoate therapy. In: Hemmersbach P, Birkeland KI, eds. Blood samples for doping control. Oslo, Norway: Pensumtjeneste, 1994: Horning H, Geyer H, Machnik M, Schänzer W, Hilkert A, Oesselmann J. Detection of exogenous testosterone by 13 C/ 12 C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (4): proceedings of the Manfred Donike Workshop on Dope Analysis. Köln: Sport und Buch Strauss, 1997: Segura J, Pascual JA, Ventura R, Ustaran JI, Cuevas A, Gonzalez R. International cooperation in analytical chemistry: experience of antidoping control at XI Pan American Games. Clin Chem 1993; 39: Pang S, Murphey W, Levine LS, Spence DA, Leon A, Lafranchi S, et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982;55: Howe CJ, Handelsman DJ. Use of filter paper for sample collection and transport in steroid pharmacology. Clin Chem 1997;43: Behre HM, Nieschlag E. Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation. In: Nieschlag E, Behre HM, eds. Testosterone action, deficiency, substitution. Berlin: Springer-Verlag, 1990: de la Torre X, Segura J, Polettini A. Detection of testosterone esters in human plasma by GC/MS and GC/MS/MS. In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (2): proceedings of the Manfred Donike Workshop on Dope Analysis. Köln: Sport und Buch Strauss, 1995: Kicman AT, Brooks RV, Collyer SC, Cowan DA, Nanjee NN, Southan GJ, et al. Criteria to indicate testosterone administration. Br J Sports Med 1990;24: Carlström K, Palonek E, Garle M, Oftebro H, Stanghelle J, Björkhem I. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 hydroxyprogesterone. Clin Chem 1992;38: Palonek E, Gottlieb C, Garle M, Björkhem I, Carlström K. Serum and urinary markers of exogenous testosterone administration. J Steroid Biochem Mol Biol 1995;55: Peng SH, Segura J, Farré M, González JC, de la Torre X. Overall biological markers of oral testosterone undecanoate misuse. In: Schänzer W, Geyer H, Gotzman A, Mareck-Engelke U, eds. Recent advances in doping analysis (6): proceedings of the Manfred Donike Workshop on Dope Analysis. Köln: Sport un Buch Strauss, 1999: Nieschlag E, Hoogen H, Bolk M, Schuster H, Wickings EJ. Clinical trial with testosterone undecanoate for male fertility control. Contraception 1978;18: Geere G, Jones J, Atherden SM, Grant DB. Plasma androgens after a single oral dose of testosterone undecanoate. Arch Dis Child 1980;55: Maisy NM, Bingham J, Marks V, English J, Chakraborty J. Clinical efficacy of testosterone undecanoate in male hypogonadism. Clin Endocrinol 1981;14: Nieschlag E, Mauss J, Coert A, Kicovic P. Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol 1975;79: Schürmeyer T, Wickings EJ, Freischem CW, Nieschlag E. Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men. Acta Endocrinol 1983;102: de la Torre X, Segura J, Polettini, Montagna M. Detection of testosterone esters in human plasma. J Mass Spectrom 1995; 30: Dehennin L, Pérès G. Plasma and urinary markers of oral testosterone misuse by healthy men in presence of masking epitestosterone administration. Int J Sports Med 1996;17: Giagulli VA, Verdonck L, Desltpere JP, Giorgino R, Vermeulen A. Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 -hydroxyandrogen glucuronides. J Clin Endocrinol Metab 1993;76: Horst HJ, Höftge WF, Dennis M, Coert A, Geelen J, Voigt KD. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr 1975;54: Coert A, Geelen J, de Visser J, van der Vies J. The pharmacology an metabolism of testosterone undecanoate (TU), a new orally active androgen. Acta Endocrinol 1975;79: Segura J. Sports. In: Karch SB, ed. Drug abuse handbook. Boca Raton, FL: CRC Press, 1998:
RECENT ADVANCES IN DOPING ANALYSIS (4)
W. SCHANZER H. GEYER A. GOTZMANN U. MARECK-ENGELKE (Editors) RECENT ADVANCES IN DOPING ANALYSIS (4) Proceedings of the Manfred Donike Workshop 14th Cologne Workshop on Dope Analysis 17th to 22nd March
More informationWADA Technical Document TD2014EAAS. Endogenous Anabolic Androgenic Steroids Measurement and Reporting
Endogenous Anabolic Androgenic Steroids Measurement and Reporting 1.0 Introduction The purpose of this Technical is to harmonize the approaches to the measurement and reporting of endogenous anabolic androgenic
More informationRECENT ADVANCES IN DOPING ANALYSIS (2)
M. DONIKE H. GEYER A. GOTZMANN U. MARECK-ENGELKE (EDITORS) RECENT ADVANCES IN DOPING ANALYSIS (2) Proceedings of the 12th Cologne Workshop on Dope Analysis 10th to 15th April 1994 SPORT und BUCH StrauB
More informationWADA Technical Document TD2016EAAS. Endogenous Anabolic Androgenic Steroids Measurement and Reporting
Endogenous Anabolic Androgenic Steroids Measurement and Reporting Introduction The purpose of this Technical Document (TD) is to harmonize the approaches to the measurement and reporting of Endogenous
More informationSPECIFIC DETECTION OF ANDROST-4-ENE-3,17-DIONE
7 SPECIFIC DETECTION OF ANDROST-4-ENE-3,17-DIONE ADMINISTRATION BY PROFILING OXYGENATED METABOLITES Abstract For the selective detection of androst-4-ene-3,17-dione ( 4-AEDIONE) administration, the analysis
More informationMay 1, By John Heim,Doug Staples
1 of 7 7/11/2014 3:39 PM May 1, 2010 By John Heim,Doug Staples Anabolic steroid screening analysis in urine is complex and labor intensive requiring sensitive instrumentation and optimized chromatographic
More informationExtend the time window for the detection of low level anabolic androgenic steroids and their metabolites
Application Note Doping Control Extend the time window for the detection of low level anabolic androgenic steroids and their metabolites Steroid profiling, screening, and confirmatory analysis using the
More informationLongterm Detection of Anabolic Steroid Metabolites in Urine
Longterm Detection of Anabolic Steroid Metabolites in Urine Application Note Forensics/Doping Control Author Stephan Baumann Agilent Technologies, Inc. 5301 Stevens Creek Blvd Santa Clara, CA 95051 USA
More informationSIMPLE, EFFICIENT AND SIMULTANEOUS DETERMINATION OF ANABOLIC STEROIDS IN HUMAN URINE
SIMPLE, EFFICIENT AND SIMULTANEOUS DETERMINATION OF ANABOLIC STEROIDS IN HUMAN URINE Pages with reference to book, From 216 To 218 S.J. Khurshid, M. Riaz, S. Ahmed ( Nuclear Chemistry Division, Pakistan
More informationPaul J. Perry, 1,3 * John H. MacIndoe, 2 William R. Yates, 1 Shane D. Scott, 3 and Timothy L. Holman 1. Toxicology
Clinical Chemistry 43:5 731 735 (1997) Drug Monitoring and Toxicology Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone
More informationWADA Technical Document TD2010EAAS. Endogenous Anabolic Androgenic Steroids Testing, Reporting and Interpretive Guidance
Endogenous Anabolic Androgenic Steroids Testing, Reporting and Interpretive Guidance 1.0 Introduction The purpose of this Technical Document is to further harmonize the approaches to the detection and
More informationMethylprednisolone detection in urine following local and oral administrations
Susana MS Simões, Marta Calçada, Luís Horta, Xavier de la Torre Methylprednisolone detection in urine following local and oral administrations Laboratório de Análises e Dopagem. Instituto do Desporto de
More informationSimultaneous Determination of a Panel of 22 Steroids in Urine and Serum by SPE and LC-MS/MS
Simultaneous Determination of a Panel of 22 Steroids in Urine and Serum by SPE and LC-MS/MS UCT Part Numbers: CUQAX22Z Clean-Up C8+QAX, 2mg/1mL BETA-GLUC- ml Beta-Glucuronidase Enzyme, liquid form SLAQID21-3UM
More informationWADA Technical Document TD2017NA
HARMONIZATION OF ANALYSIS AND REPORTING OF 19-NORSTEROIDS RELATED TO NANDROLONE 1.0 Introduction This document has been established to harmonize the Confirmation Procedure for the analysis and reporting
More informationWADA Technical Document TD2018EAAS. Endogenous Anabolic Androgenic Steroids Measurement and Reporting
Endogenous Anabolic Androgenic Steroids Measurement and Reporting 1.0 Introduction The purpose of this Technical Document (TD) is to harmonize the approaches to the measurement and reporting of Endogenous
More informationTrace-Level Analysis of Metanephrines in Plasma by HILIC LC-MS/MS
Abstract Highly sensitive analysis of metanephrines in plasma is critical in the diagnosis and treatment of pheochromocytoma and paraganglioma. Here, a HILIC LC-MS/MS method was developed using a Raptor
More informationDISCUSSION:PERSPECTIVES OF STEROID PROFILING
10 DISCUSSION:PERSPECTIVES OF STEROID PROFILING REVIEWED STEROID PROFILING AND TESTOSTERONE Initially, the abuse of steroids in sports was focussed on chemically modified derivatives of testosterone. These
More informationNational Institute for Public Health and the Environment Annual CRL workshop 22 October Update on natural Hormone studies
2008 Annual CRL workshop 22 October 2008 Update on natural Hormone studies Natural hormone studies: update Possible approaches - C12/C13 ratio: can result in proof of abuse - Determination of intact esters
More informationextraction of EG and DEG from the matrix. However, the addition of all diluent at once resulted in poor recoveries.
Informal Commentary Limit of Diethylene Glycol (DEG) and Ethylene Glycol (EG) in Sorbitol Solution, Sorbitol Sorbitan Solution and Noncrystallizing Sorbitol Solution December 2009 Monograph/Section(s):
More informationDevelopment of a Clinical Research Method for the Measurement of Testosterone. Dihydrotestosterone
Development of a Clinical Research Method for the Measurement of Testosterone and Dihydrotestosterone Martijn van Faassen, Maarten van den Noort and Ido Kima University Medical Center, Groningen, Netherlands
More informationThe Effect of Oral Dehydroepiandrosterone (DHEA) on the Urine Testosterone/Epitestosterone (T/E) Ratio in Human Male Volunteers*
The Effect of Oral Dehydroepiandrosterone (DHEA) on the Urine Testosterone/Epitestosterone (T/E) Ratio in Human Male Volunteers* Thomas Z. Bosy 1, Karla A. Moore 1,t, and Alphonse Poklis 2 I Armed Forces
More informationRECENT ADVANCES IN DOPING ANALYSIS (5)
W. SCHANZER H. GEYER A. GOTZMANN U. MARECK-ENGELKE (EDITORS) RECENT ADVANCES IN DOPING ANALYSIS (5) Proceedings of the Manfred Donike Workshop 15th Cologne Workshop on Dope Analysis 23rd to 28th February
More informationIntroduction to the Doping Problem
Introduction to the Doping Problem Jordi Segura Director, WADA Accredited Antidoping Laboratory, IMIM-Hospital del Mar, Barcelona, Spain Doping and Society: towards the perfect human machine? ESOF, Barcelona
More informationWADA Technical Document TD2018MRPL
MINIMUM REQUIRED PERFORMANCE LEVELS FOR DETECTION AND IDENTIFICATION OF NON-THRESHOLD SUBSTANCES In order to ensure that all WADA-accredited Laboratories can report the presence of Prohibited Substances,
More informationSample purification procedure for confirmation of 3 -hydroxy stanozolol by gas chromatography/high resolution mass spectrometry
Author proof done Research Article Sample purification procedure for confirmation of 3 -hydroxy stanozolol by gas chromatography/high resolution mass spectrometry S. Ahi, I. M. Reddy, A. Beotra, R. Lal,
More informationNow it is. easy to switch. CHS TM Steroid Profiling kit and software. Brochure not for distribution in the USA and Canada
Now it is easy to switch to Clinical MSMS CHS TM Steroid Profiling kit and software Brochure not for distribution in the USA and Canada 2 Meeting your needs for steroid assays PerkinElmer s new CHS MSMS
More informationTESTOFEN HUMAN CLINICAL TRIAL GENCOR PACIFIC, INC. Copyright 2006 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920 E. Orangethorpe Avenue, Suite B, Anaheim, CA 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com gita@gencorpacific.com www.gencorpacific.com TESTOFEN
More informationGC-MS(/MS) investigations on long-term metabolites of 17-methyl steroids
M.K. Parr 1), G. Fußhöller 1), M. Gütschow 2), C. Hess 1,2), W. Schänzer 1) GC-MS(/MS) investigations on long-term metabolites of 17-methyl steroids 1) Institute of Biochemistry, German Sport University,
More information3. Coupled Techniques in Thermal Analysis
3. Coupled Techniques in Thermal Analysis Coupled Techniques in Thermal Analysis as Evolved Gas Analysis (EGA) TG/FT-IR Technique for analyzing gas evolved from TG with FT-IR TG/MS Technique for analyzing
More informationCORESTA RECOMMENDED METHOD Nº 67
CORESTA RECOMMENDED METHOD Nº 67 DETERMINATION OF WATER IN THE MAINSTREAM SMOKE OF CIGARS BY GAS CHROMATOGRAPHIC ANALYSIS (November 2005) 1. FIELD OF APPLICATION The method is applicable to the particulate
More informationAndrogen Measurements
Chapter 5 / Androgen Measurements 63 Androgen Measurements Methods, Interpretation, and Limitations 5 Frank Z. Stanczyk SUMMARY Androgens are measured primarily in serum by direct and indirect (with one
More informationInfluence on the alternative steroid profile, part I
Van Renterghem P, Deventer K, Van Eenoo P Influence on the alternative steroid profile, part I DoCoLab, Ghent University, Ghent, Belgium Abstract To date, knowledge of steroid profiling has gone beyond
More informationEVALUATION OF INFLUENTIAL FACTORS ON THE T/E RATIO AS DETERMINED IN DOPING ANALYSIS ABSTRACT
1 EVALUATION OF INFLUENTIAL FACTORS ON THE T/E RATIO AS DETERMINED IN DOPING ANALYSIS ABSTRACT The ratio of the concentration of testosterone glucuronide to the concentration of epitestosterone glucuronide
More informationHigh speed UHPLC-MS/MS determination of multiple steroids in human serum using the Nexera MX system for multiplex analysis
PO-CON695E High speed UHPLC-MS/MS determination of multiple steroids in human serum using the Nexera MX system for multiplex analysis MSACL 6 EU Neil Loftus, Stephane Moreau, Mikaël Levi 3, Anja Grüning
More informationMonitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc.
Mr Mark Newman Monitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc. 2 Avoiding Pitfalls in (B)HRT Monitoring and Picking the Right Lab Test Objectives: Outline how expected
More informationRapid Analysis of Metanephrine and Normetanephrine in Urine by Gas Chromatography Mass Spectrometry
Clinical Chemistry 48:2 332 337 (2002) Endocrinology and Metabolism Rapid Analysis of Metanephrine and Normetanephrine in Urine by Gas Chromatography Mass Spectrometry David K. Crockett, 1* Elizabeth L.
More informationDETERMINATION OF TETRAHYDROTHIOPHENE IN AMBIENT AIR BY GAS CHROMATOGRAPHY WITH A PFPD DETECTOR COUPLED TO A PRECONCENTRATION TECHNOLOGY
DETERMINATION OF TETRAHYDROTHIOPHENE IN AMBIENT AIR BY GAS CHROMATOGRAPHY WITH A PFPD DETECTOR COUPLED TO A PRECONCENTRATION TECHNOLOGY Nengbing Xu, Hongmei Ying and Libo Zhu Ningbo Environmental Monitoring
More informationGases&Technology. Measurement of Impurities in Helium Using the Dielectric Barrier Discharge Helium Ionization Detector. FEATURE.
Gases&Technology FEATURE Measurement of Impurities in Helium Using the Dielectric Barrier Discharge Helium Ionization Detector. B Y M A T T H E W M O N A G L E Abstract Bulk gases are often delivered to
More informationRayBio Human vwf ELISA Kit
RayBio Human vwf ELISA Kit Catalog #: ELH-vWF User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross, GA
More informationExtended Application Note
Extended Application Note Harmful Substances in Dietary Supplements HPLC Columns with APP A-337 www.mtc-usa.com 1-732-578-1777 INTRODUCTION A dietary supplement is a substance to be consumed for the purpose
More informationQUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19- NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY
0090-9556/06/3408-1328 1335$20.00 DRUG METABOLISM AND DISPOSITION Vol. 34, No. 8 Copyright 2006 by The American Society for Pharmacology and Experimental Therapeutics 10165/3129438 DMD 34:1328 1335, 2006
More informationPros and Cons of Hormone Testing in Different Body Fluids with Different Routes of Hormone Delivery
Pros and Cons of Hormone Testing in Different Body Fluids with Different Routes of Hormone Delivery David T Zava, PhD ZRT laboratory A Guide to Steroid Hormone Testing in Different Body Fluids Following
More informationOMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (16) 17 R QUALIFICATION OF EQUIPMENT ANNEX 2: QUALIFICATION OF GC EQUIPMENT Full document title and reference Document type Legislative
More informationTechnical Procedure for Drug Chemistry Gas Chromatograph/Mass Spectrometry (GC-MS)
Technical Procedure for Drug Chemistry Gas Chromatograph/Mass Spectrometry (GC-MS) 1.0 Purpose - This procedure specifies the required elements for the calibration and use of the Agilent 6890 GC interfaced
More informationRECENT ADVANCES IN DOPING ANALYSIS (8)
w. SCHANZER H. GEYER A. GOTZMANN U. MARECK-ENGELKE (EDITORS) RECENT ADVANCES IN DOPING ANALYSIS (8) Proceedings of the Manfred Donike Workshop 18th Cologne Workshop on Dope Analysis 20th to 25th February
More informationIdentification of Testosterone and Testosterone Esters in Human Hair
Identification of Testosterone and Testosterone Esters in Human Hair P. Kintz*, V. Cirimele, T. Jeanneau, and B. Ludes Institut de M~decine L~gale, 11 rue Humann, 67 Strasbourg, France Abstract In t 974,
More informationPublic Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended
Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Andriol Testocaps, Sustanon and Testosterone Implants [] NL/W/0026/pdWS/001
More informationLaboratory Hardware. Custom Gas Chromatography Solutions WASSON - ECE INSTRUMENTATION. Custom solutions for your analytical needs.
Laboratory Hardware Custom Gas Chromatography Solutions Custom solutions for your analytical needs. Laboratory Hardware Wasson-ECE Instrumentation offers hardware-only solutions for advanced chromatography
More informationMETHOD 3C - DETERMINATION OF CARBON DIOXIDE, METHANE, NITROGEN, AND OXYGEN FROM STATIONARY SOURCES
METHOD 3C - DETERMINATION OF CARBON DIOXIDE, METHANE, NITROGEN, AND OXYGEN FROM STATIONARY SOURCES 1. Applicability and Principle 1.1 Applicability. This method applies to the analysis of carbon dioxide
More informationMSD 96-Well MULTI-ARRAY and MULTI-SPOT Human Granulocyte Colony Stimulating Factor (hg-csf) Ultrasensitive Assay
MSD 96-Well MULTI-ARRAY and MULTI-SPOT Human Granulocyte Colony Stimulating Factor (hg-csf) Ultrasensitive Assay Summary This assay measures Human Granulocyte Colony Stimulating Factor (G-CSF) in a 96-well
More informationRapid and Reliable Detection of Dissolved Gases in Water
Rapid and Reliable Detection of Dissolved Gases in Water Andrea Caruso and Massimo Santoro Thermo Fisher Scientific, Milan, Italy Application Note 005 Key Words Chromeleon CDS, Environmental, Fracking,
More informationsteroids 73 (2008) available at journal homepage:
steroids 73 (2008) 751 759 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/steroids Gas chromatography mass spectrometry method for the analysis of 19-nor-4-androstenediol
More informationStudies on the determination of chlorotestosterone and its metabolites in bovine urine
Studies on the determination of chlorotestosterone and its metabolites in bovine urine Michaela Walshe, a Michael Keeffe a and Bruno Le Bizec b a Teagasc, The National Food Centre, Dunsinea, Castleknock,
More informationThe ICL Insider. Lab Testing: Testosterone. In This Issue. The Debate
The ICL Insider February 2017 Volume 2, Issue 2 Lab Testing: Testosterone In This Issue Testosterone shashtilak@iclabs.ca Next Issue: Expected Release April 2017 The Debate Aging is accompanied by various
More informationi) Research Papers in peer-reviewed journals
Dr Kicman Publications List: Currently 46 Research Papers Published in Journals, with another 3 Papers in Submission/Press, 14 Reviews published in Journals/Books and 5 Extended Proceedings. i) Research
More informationEvaluation of Testosterone/Epitestosterone Ratio Influential Factors as Determined in Doping Analysis
Iournal of Analytical Toxicology, Vol. 24, March 2000 Evaluation of Testosterone/Epitestosterone Ratio Influential Factors as Determined in Doping Analysis D.H. van de Kerkhofl,*, D. de Boer 1,2, J.H.H.
More informationChapter 5. General discussion
Chapter 5. General discussion 127 Chapter 5 In 2003, two review papers concluded that endogenous androgens do not show any consistent association with cardiovascular disease (CVD) risk 1,2. Apparently,
More informationUWW ANTI-DOPING PANEL DECISION. Case
UWW ANTI-DOPING PANEL DECISION Case United World Wrestling (UWW) v. Mr Husham Majeed Ali AL THAALEBI (Athlete GR wrestling member of the Iraqi national team) Panel: - Dr Daniel Wozniak - Dr Milica Vukasinovic-Vesic
More informationAnalysis of Benzenesulfonic Acid and P-Toluenesufonic Acid Esters in Genotox Monitoring using UPLC/UV-MS
Analysis of Benzenesulfonic Acid and P-Toluenesufonic Acid Esters in Genotox Monitoring using UPLC/UV-MS Peter Alden and Michael Jones Waters Corporation, Milford, MA, U.S. APPLICATION BENEFITS UPLC combines
More informationGCMSD-Headspace Analysis SOP
Before you start GCMSD-Headspace Analysis SOP Method and Sequences names are restricted to 50 characters (MSD program will crash otherwise) The GC oven and Injection Ports need to be cooled to 50 oc to
More informationMen with hypogonadism require testosterone replacement
Journal of Andrology, Vol. 24, No. 5, September/October 2003 Copyright American Society of Andrology Oral Testosterone-Triglyceride Conjugate in Rabbits: Single-Dose Pharmacokinetics and Comparison With
More informationRetention Time Locking: Concepts and Applications. Application
Retention Time Locking: Concepts and Applications Application Gas Chromatography December 1997 Authors Vince Giarrocco Bruce Quimby Matthew Klee Agilent Technologies, Inc. 2850 Centerville Road Wilmington,
More informationLCMSMS Solutions For Steroid Analysis
LCMSMS Solutions For Steroid Analysis Dan Blake Manager, Clinical Applications For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-18-1166-A Agenda Special considerations for steroid analysis
More informationab IgG1 Human ELISA Kit
ab100548 IgG1 Human ELISA Kit Instructions for Use For the quantitative measurement of Human IgG1 in serum and plasma This product is for research use only and is not intended for diagnostic use. Version
More informationTESTOFEN. Anabolic & Androgenic Activity GENCOR PACIFIC, INC. Fenugreek Extract standardized for FENUSIDE TM. Copyright 2005 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920E. Orangethorpe Avenue, Suite B, Anaheim, CA. 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com manu@gencorpacific.com www.gencorpacific.com TESTOFEN
More informationThe Application of QuEChERS in the Extraction of Anabolic Steroids in Whole Blood
The Application of QuEChERS in the Extraction of Anabolic Steroids in Whole Blood UCT Part Numbers: ECQUUS1015CT- Enviro-Clean 15 ml centrifuge tube with 400 mg MgSO 4 and 100 mg NaCl CUMPS2CT - Enviro-Clean
More informationBeyond Analytical Results
WADA / Science and Investigations Symposium - Istanbul Beyond Analytical Results Martial Saugy, Norbert Baume, Neil Robinson, Nicolas Jan, François Marclay Swiss Laboratory for Doping Analyses Centre Hospitalier
More informationInternational Journal of Generic Drugs ANALYTICAL METHOD PROCEDURES THIS SOP IS 'SWITCHED : OFF : ON'
DISSOLUTION ASSAY Release & Stability Studies Ed. 04. General Index: 1. PRODUCT SPECIFICATIONS (USP MONOGRAPH) 2. IDENTIFICATION BY HPLC 3. ASSAY - HPLC SETUP 4. STANDARD PREPARATION 5. SYSTEM SUITABILITY
More informationExperiment GC : Analysis of BTEX by GC-FID
46 Experiment GC : Analysis of BTEX by GC-FID Learning Goals: Familiarity with gas chromatography Gain experience in temperature programming and method development Correctly use an internal standard, and
More informationGas Chromatography. MS Vent Enhancement to the PreVent System to Optimize Operation with the TurboMass, TurboMass Gold, and Clarus 500 GC/MS Systems
Inorganic Analysis Chromatography Molecular Spectroscopy Thermal/Elemental Analysis Informatics Gas Chromatography MS Vent Enhancement to the PreVent System to Optimize Operation with the TurboMass, TurboMass
More informationEFFECTS OF REVIVOGEN SCALP THERAPY ON TESTOSTERONE METABOLISM IN RECONSTRUCTED HUMAN EPIDERMIS
IN VITRO BIOLOGICAL TESTING BIOalternatives The state-of-the-art laboratory Proposal n : AD070315C-2 Study n : AD070315B EFFECTS OF REVIVOGEN SCALP THERAPY ON TESTOSTERONE METABOLISM IN RECONSTRUCTED HUMAN
More informationPerformance Profiling: A Role for Sport Science in the Fight Against Doping?
TECHNICAL REPORT International Journal of Sports Physiology and Performance, 2009, 4, 129-133 2009 Human Kinetics, Inc. Performance Profiling: A Role for Sport Science in the Fight Against Doping? Yorck
More information1. INTRODUCTION CH 3 CH3
1. ITRODUCTIO TITLE: Analysis of stanozolol and metabolites S.O.P. : ARO/446 in urine Page : 1 of 12 This method describes the analysis of stanozolol, 4ß-hydroxy-stanozolol and 16ß-hydroxy-stanozolol in
More informationProtocol for the verification tests on ethylene oxide treatment technology
Pilot project for the environmental technology verification In the field of ethylene oxide treatment technology Protocol for the verification tests on ethylene oxide treatment technology Sept. 11, 2003
More informationLaboratory Hardware. Custom Gas Chromatography Solutions WASSON - ECE INSTRUMENTATION. Engineered Solutions, Guaranteed Results.
Laboratory Hardware Custom Gas Chromatography Solutions Engineered Solutions, Guaranteed Results. WASSON - ECE INSTRUMENTATION Laboratory Hardware Wasson-ECE Instrumentation offers hardware-only solutions
More informationViapath Innovation Academy 5 December 2014
Viapath Innovation Academy 5 December 2014 Interview with Dr Andrew Kicman of King s College London conducted by Robert Dunn of the Future Leaders in Innovation Group, Viapath. How did you choose your
More informationKNG1 (Human) ELISA Kit
KNG1 (Human) ELISA Kit Catalog Number KA1040 96 assays Version: 07 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationSports drug testing an analyst s perspective
Sports drug testing an analyst s perspective Graham J. Trout and Rymantas Kazlauskas Australian Sports Drug Testing Laboratory, Australian Government Analytical Laboratories, Sydney, Australia. E-mail:
More informationStatistical discrimination of steroid profiles introduction of steroidomics in doping analysis
P. Van Renterghem a, Pierre-Edouard Sottas b, Martial Saugy b, F.T. Delbeke a, P. Van Eenoo a Statistical discrimination of steroid profiles introduction of steroidomics in doping analysis a DoCoLab -
More informationGas Clean. Filters. Delivering Clean Gases for GC and GC/MS Operation
Gas Clean Filters Delivering Clean Gases for GC and GC/MS Operation Gas Clean Filters Fast, leak-free replacement without tools! Each Gas Clean Filter features a unique quick disconnect design which allows
More informationSimplified Backflush Using Agilent 6890 GC Post Run Command Application Note
Simplified Backflush Using Agilent 6890 GC Post Run Command Application Note Gas Chromatography Author Matthew S. Klee Agilent Technologies 2850 Centerville Road Wilmington, DE 19808-1610 USA Abstract
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other METHYL ANDROID METHITEST METHYL TESTRED 01404 ROUTE MISCELL. CYPIONATE ENANTHATE GUIDELINES FOR USE ANDRODERM ANDROGEL AXIRON FORTESTA NATESTO STRIANT TESTIM VOGELXO
More informationRayBio Human TNF-alpha ELISA Kit
RayBio Human TNF-alpha ELISA Kit Catalog #: ELH-TNFa User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,
More information6I unstable compound with phosphoric acid, which disappears during fatigue. (From the Department of Physiology, The University, Sheffield.
6I2.744 ON THE CREATINE AND PHOSPHORUS CONTENT OF MUSCLE. BY MARION BROWN1 AND C. G. IMRIE. (From the Department of Physiology, The University, Sheffield.) IT is well known that the concentration of creatine
More informationEFFECTS OF CLEAROGEN ACNE LOTION ON TESTOSTERONE METABOLISM IN RECONSTRUCTED HUMAN EPIDERMIS
IN VITRO BIOLOGICAL TESTING BIOalternatives The state-of-the-art laboratory Proposal n : AD070315C-2 Study n : AD070315A EFFECTS OF CLEAROGEN ACNE LOTION ON TESTOSTERONE METABOLISM IN RECONSTRUCTED HUMAN
More informationUsing the PreVent System in Time-Saver Mode with the AutoSystem XL Gas Chromatograph and the TurboMass Mass Spectrometer
application Note Gas Chromatography/ Mass Spectrometry Using the PreVent System in Time-Saver Mode with the AutoSystem XL Gas Chromatograph and the TurboMass Mass Spectrometer Overview A mass spectrometer
More informationCHE 4115 Chemical Processes Laboratory 2 Experiment 1. Batch Distillation
CHE 4115 Chemical Processes Laboratory 2 Experiment 1 Batch Distillation BACKGROUND Distillation is one of the most commonly used unit operations in chemical engineering. In general, a distillation operation
More informationno peaks missing peaks too small peaks increasing retention decreasing retention
GC Troubleshooting We can help you. 1. Observation: no peaks no peaks missing peaks too small peaks increasing retention decreasing retention declining baseline rising baseline bleeding plateaus interfering
More informationApplications of a Magnetic Sector Process Mass Spectrometer to the Analysis of Variable Vacuum Samples
Applications of a Magnetic Sector Process Mass Spectrometer to the Analysis of Variable Vacuum Samples Outline of Presentation Introduction Process Gas Analysis Magnetic Sector Mass Spectrometer Standard
More informationTestosterone Topical/Buccal/Nasal
BENEFIT APPLICATION Testosterone Topical/Buccal/Nasal DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations
More informationM0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:
M0BCore Safety Profile Active substance: Finasteride Pharmaceutical form(s)/strength: 5 mg P-RMS: SE/H/PSUR/0002/006 Date of FAR: 16.05.2014 4.3 Contraindications Finasteride is not indicated for use in
More informationComparative analysis of mass spectral matching for confident compound identification using the Advanced Electron Ionization source for GC-MS
TECHNICAL NOTE 1598 Comparative analysis of mass spectral matching for confident compound identification using the Advanced Electron Ionization source for GC-MS Authors Amit Gujar, 1 Tim Anderson, 1 Daniela
More informationAutomated Determination of Dissolved Gases in Water Anne Jurek. Abstract: Discussion:
Automated Determination of Dissolved Gases in Water Anne Jurek Abstract: The RSK-175 standard operating procedure was developed in order to determine the amount of dissolved gas in water. Due to the expansion
More informationToxicology Gas Chromatography-Mass Spectrometry (GC-MS)
Toxicology Gas Chromatography-Mass Spectrometry (GC-MS) 1.0 Purpose - This procedure specifies the required elements for the calibration and use of the Agilent Gas Chromatograph interfaced to the Agilent
More informationWeiyi Zheng, Xiaoxia Dong, Evan Rogers, Jimmie C. Oxley, and James L. Smith*
Improvements in the Determination of Decomposition Gases from 1,3,3-Trinitroazetidine and 5-Nitro-2,4-dihydro-3H-1,2,4,-trizol-3-one using Capillary Gas Chromatography-Mass Spectrometry Weiyi Zheng, Xiaoxia
More informationCarrier Gases in Capillary GC
Carrier Gases in Capillary GC LC Columns and Consumables Mark Sinnott Application Engineer January 15, 2009 CARRIER GAS Mobile Phase Carries the solutes down the column Selection and velocity influences
More informationTestosterone ELISA Kit
Testosterone ELISA Kit Catalog Number KA3396 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationRat myeloperoxidase-antineutrophil cytoplasmic antibody(mpo-anca) ELISA Kit
Rat myeloperoxidase-antineutrophil cytoplasmic antibody(mpo-anca) ELISA Kit Catalog Number. CSB-E08675r For the quantitative determination of rat myeloperoxidase-antineutrophil cytoplasmic antibody(mpo-anca)
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Myodine 25 mg/ml solution for injection for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Nandrodine laurate 25
More informationSyed Ghulam Musharraf 1,2* and Umair Gulzar 2
Musharraf and Gulzar Chemistry Central Journal 2012, 6:54 RESEARCH ARTICLE Open Access Effective separation and simultaneous analysis of anabolic androgenic steroids (AAS) in their pharmaceutical formulations
More information